First U.S. Injective ETF Begins Trading on Nasdaq With Staking

A U.S. exchange-traded fund tracking Injective (INJ) began trading on Nasdaq, giving investors a way to gain token exposure through a standard brokerage account while the product plans to stake as much as 90% of its holdings.

Injective announced Friday that the fund trades under the ticker INJC and is the first U.S. ETF to track INJ. The product is listed on Nasdaq.

BitGo holds the fund’s spot INJ. It plans to stake up to 90% of its holdings and automatically reinvest net staking proceeds.

Investors can access INJ through a standard securities brokerage account without creating a crypto wallet or opening an account on a crypto trading platform. A separate wallet or crypto platform account is not required. The product keeps token custody with BitGo while giving investors market exposure through a traditional account.

The launch adds Injective to a short list of crypto assets with dedicated U.S. ETFs, alongside Bitcoin (BTC), Ether (ETH) and Solana (SOL).